Early research (Phase 1)UnknownNCT02860559
What this trial is testing
Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency
Who this might be right for
Severe Combined Immunodeficiency
Taiga Biotechnologies, Inc. 8